Anna Darabi
11 – 20 of 54
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Unequivocal identification of intracellular aluminium adjuvant in a monocytic THP-1 cell line.
(
- Contribution to journal › Article
-
Mark
Intratumorally implanted mesenchymal stromal cells potentiate peripheral immunotherapy against malignant rat gliomas.
(
- Contribution to journal › Article
-
Mark
Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma.
(
- Contribution to journal › Article
-
Mark
Intratumoral COX-2 inhibition enhances GM-CSF immunotherapy against established mouse GL261 brain tumors.
(
- Contribution to journal › Article
-
Mark
HLA-I Antigen Presentation and Tapasin Influence Immune Responses Against Malignant Brain Tumors - Considerations for Successful Immunotherapy.
(
- Contribution to journal › Article
-
Mark
Immunizations with unmodified tumor cells and simultaneous COX-2 inhibition eradicate malignant rat brain tumors and induce a long-lasting CD8(+) T cell memory.
(
- Contribution to journal › Article
- 2013
-
Mark
Aluminium based adjuvants and their effects on mitochondria and lysosomes of phagocytosing cells
(
- Contribution to journal › Article
-
Mark
IFNγ in combination with IL-7 enhances immunotherapy in two rat glioma models.
(
- Contribution to journal › Article
-
Mark
PD-L1 Expression by Neurons Nearby Tumors Indicates Better Prognosis in Glioblastoma Patients.
(
- Contribution to journal › Article
-
Mark
Intratumoral temozolomide synergizes with immunotherapy in a T cell-dependent fashion.
(
- Contribution to journal › Article